Trigran Investments’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.6M Sell
7,173,770
-1,339
-0% -$4.89K 5.07% 11
2026
Q1
$28.3M Buy
7,175,109
+1,011,725
+16% +$5.1M 6.78% 9
2025
Q4
$41.7M Sell
6,163,384
-1,537,644
-20% -$10.8M 8.22% 5
2025
Q3
$53.8M Sell
7,701,028
-689,430
-8% -$4.79M 9.74% 3
2025
Q2
$51.3M Buy
8,390,458
+790,901
+10% +$5.26M 8.9% 4
2025
Q1
$57.8M Sell
7,599,557
-21,960
-0.3% -$183K 8.5% 5
2024
Q4
$73.3M Sell
7,621,517
-68,852
-0.9% -$536K 8.43% 4
2024
Q3
$45.5M Buy
7,690,369
+3,211,623
+72% +$21.3M 4.98% 10
2024
Q2
$31M Buy
4,478,746
+1,221,797
+38% +$8.59M 3.25% 16
2024
Q1
$25.1M Buy
+3,256,949
New +$26.2M 2.43% 14

Other funds holding MDXG

Trigran Investments's MDXG Position: Q2 2026 in Review

Trigran Investments reduced its MiMedx Group (MDXG) stake by 0.02% in Q2 2026, selling an estimated $4.89K and leaving 7,173,770 shares worth $27.6M. The position accounts for 5.07% of the portfolio, ranked #11.

Trigran Investments first reported a position in MDXG in Q1 2024 and has held it in 10 quarters since. The position peaked at $73.3M in Q4 2024. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Trigran Investments held 7,173,770 shares of MiMedx Group worth $27.6M as of Q2 2026.
  • Trigran Investments sold 1,339 MiMedx Group shares in Q2 2026, an estimated $4.89K.
  • MiMedx Group made up 5.07% of Trigran Investments's portfolio in Q2 2026, its #11 holding.
  • Trigran Investments first reported a position in MiMedx Group in Q1 2024 and has held it in 10 quarters since.
  • Trigran Investments's MiMedx Group position peaked at $73.3M in Q4 2024.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Trigran Investments's 13F filing for Q2 2026, filed 12 Aug 2026.